NY A09957 | 2017-2018 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 43-0)
Status: Engrossed on March 13 2018 - 50% progression, died in committee
Action: 2018-03-13 - REFERRED TO INSURANCE
Pending: Senate Insurance Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Enacts the "comprehensive contraception coverage act" to provide insurance coverage for FDA-approved contraceptive drugs, devices and products.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Enacts the "comprehensive contraception coverage act" to provide insurance coverage for FDA-approved contraceptive drugs, devices and products.

Sponsors


Roll Calls

2018-03-13 - Assembly - Assembly Floor Vote - Final Passage (Y: 101 N: 35 NV: 0 Abs: 5) [PASS]
2018-03-06 - Assembly - Assembly Rules Committee: Favorable (Y: 21 N: 4 NV: 0 Abs: 6) [PASS]
2018-03-06 - Assembly - Assembly Rules Committee: Favorable (Y: 21 N: 4 NV: 0 Abs: 6) [PASS]
2018-03-05 - Assembly - Assembly Insurance Committee: Favorable refer to committee Codes (Y: 17 N: 7 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2018-03-13SenateREFERRED TO INSURANCE
2018-03-13Assemblydelivered to senate
2018-03-13Assemblypassed assembly
2018-03-06Assemblyordered to third reading rules cal.11
2018-03-06Assemblyrules report cal.11
2018-03-06Assemblyreported
2018-03-05Assemblyreported referred to rules
2018-03-05Assemblyreported referred to codes
2018-03-01Assemblyreferred to insurance

New York State Sources

TypeSource
Summaryhttps://assembly.state.ny.us/leg/?default_fld=&bn=A09957&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y
Texthttps://assembly.state.ny.us/leg/?default_fld=&bn=A09957&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#A09957
Roll Callhttps://assembly.state.ny.us/leg/?default_fld=&bn=A09957&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#AC1
Roll Callhttps://assembly.state.ny.us/leg/?default_fld=&bn=A09957&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#AC2
Roll Callhttps://assembly.state.ny.us/leg/?default_fld=&bn=A09957&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#AC3
Roll Callhttps://assembly.state.ny.us/leg/?default_fld=&bn=A09957&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#AF1

Bill Comments

feedback